2023
Association of Recent and Past Suicide Attempts With Health-Related Quality of Life.
Bommersbach T, Rosenheck R, Rhee T. Association of Recent and Past Suicide Attempts With Health-Related Quality of Life. The Journal Of Clinical Psychiatry 2023, 84 PMID: 36856537, DOI: 10.4088/jcp.22m14441.Peer-Reviewed Original ResearchConceptsMental component scorePhysical component scoreSuicide prevention initiativesSuicide attemptsOverall health-related qualityMajor public health priorityPrevention initiativesHealth-related qualitySubstance use comorbiditiesMeasures of HRQOLRelated Conditions Wave IIILower MCS scoresMultivariable regression analysisPublic health prioritySubstance use disordersComponent scoresNational Epidemiologic SurveyQuality of lifeRecent suicide attemptAssociation of suicidePast suicide attemptsPrior attemptsMCS scoresUnadjusted analysesHealth priority
2019
High Risk of Alcohol-Impaired Driving in Adults With Comorbid Alcohol and Substance Use Disorders in the U.S. Population.
Roberts W, Moore KE, Pittman BP, Fillmore MT, McKee SA. High Risk of Alcohol-Impaired Driving in Adults With Comorbid Alcohol and Substance Use Disorders in the U.S. Population. Journal Of Studies On Alcohol And Drugs 2019, 80: 114-119. PMID: 30807283, PMCID: PMC6396510, DOI: 10.15288/jsad.2019.80.114.Peer-Reviewed Original ResearchConceptsSubstance use disordersAlcohol use disorderComorbid substance use disorderUse disordersSUD diagnosisHigh riskAssociated Disabilities Interview Schedule-5Alcohol-impaired drivingPast-year alcohol use disorderSubstance use comorbiditiesNational Epidemiologic SurveyDSM-5 criteriaAlcohol-impaired driving behaviorIncreased oddsComorbid alcoholQuantity/frequencyHigher oddsPast-year drinkersEpidemiologic SurveyRelated conditionsAUD severityU.S. populationDisordersOddsCannabis legalization
2018
Mental health multimorbidity and poor quality of life in patients with schizophrenia
Bhalla IP, Stefanovics EA, Rosenheck RA. Mental health multimorbidity and poor quality of life in patients with schizophrenia. Schizophrenia Research 2018, 201: 39-45. PMID: 29709490, DOI: 10.1016/j.schres.2018.04.035.Peer-Reviewed Original ResearchConceptsAdditional psychiatric comorbiditySubstance use disordersPsychiatric comorbidityPsychiatric disordersUse disordersMental health multimorbiditySubstance use comorbiditiesAdditional psychiatric disordersComorbid psychiatric disordersComorbid substance useComplex clinical presentationClinical Antipsychotic TrialsSelf-reported QoLSimilar adverse effectsMultimorbidity frameworkPoor qualityClinical presentationWorse QOLBetter QOLAntipsychotic TrialsComorbiditiesDual diagnosisQoLPatientsMultimorbidity
2017
The relative influence of individual risk factors for attempted suicide in patients with bipolar I versus bipolar II disorder
Bobo WV, Na PJ, Geske JR, McElroy SL, Frye MA, Biernacka JM. The relative influence of individual risk factors for attempted suicide in patients with bipolar I versus bipolar II disorder. Journal Of Affective Disorders 2017, 225: 489-494. PMID: 28865370, DOI: 10.1016/j.jad.2017.08.076.Peer-Reviewed Original ResearchConceptsBody mass indexLifetime suicide attemptsRisk factorsBD-IISuicide attemptsAcute psychiatric problemsSubstance use comorbiditiesStrong risk factorCross-sectional cohortPrevalence of lifetimeBD II patientsMayo Clinic Bipolar Disorder BiobankIndividual risk factorsRapid cyclingRisk of lifetimeEntire cohortIllness onsetMass indexClinical variablesFemale sexIllness coursePsychiatric hospitalizationSuicidal patientsPsychiatric problemsStandardized questionnaire
2014
Buprenorphine/Naloxone Dose and Pain Intensity Among Individuals Initiating Treatment for Opioid Use Disorder
Becker WC, Ganoczy D, Fiellin DA, Bohnert AS. Buprenorphine/Naloxone Dose and Pain Intensity Among Individuals Initiating Treatment for Opioid Use Disorder. Journal Of Substance Use And Addiction Treatment 2014, 48: 128-131. PMID: 25312475, DOI: 10.1016/j.jsat.2014.09.007.Peer-Reviewed Original ResearchConceptsOpioid use disorderNumerical rating scoreBUP/NXPain intensityUse disordersPrimary outcomeBuprenorphine/naloxone doseDecreased pain intensityFull agonist opioidsImproved pain intensityBuprenorphine/naloxoneSubset of patientsSubstance use comorbiditiesChronic pain diagnosesPartial agonist propertiesEligible patientsNX treatmentAgonist opioidsPain levelsNaloxone doseComorbid painMultivariable analysisMaintenance treatmentMean ageClinical correlates
2010
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet 2010, 376: 367-387. PMID: 20650518, PMCID: PMC4855280, DOI: 10.1016/s0140-6736(10)60829-x.Peer-Reviewed Original ResearchMeSH KeywordsAIDS-Related Opportunistic InfectionsAnti-HIV AgentsAntipsychotic AgentsAntitubercular AgentsAntiviral AgentsBacterial InfectionsComorbidityCriminal LawDrug InteractionsDrug Resistance, BacterialEvidence-Based MedicineHepatitis, Viral, HumanHIV InfectionsHumansMedication AdherenceMental DisordersNarcoticsPrisonersSubstance-Related DisordersTuberculosisConceptsSubstance use disordersDrug usersAntiretroviral therapyViral hepatitisHIV treatmentHealth of HIVPharmacokinetic drug interactionsSubstance use comorbiditiesMedication-Assisted TherapyEvidence-based treatmentsDrug-resistant strainsHealth-related outcomesHealth service deliveryInfectious complicationsMultiple comorbiditiesHIV infectionPsychiatric comorbidityPoor adherenceClinical managementCardiovascular diseaseInadequate prescriptionCongregate settingsDrug interactionsComorbiditiesHIV
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply